Schizophrenia is a mental health disorder that affects about 24 million people worldwide, or roughly one in 300 people, according to the World Health Organization (WHO). It often leads to significant challenges in daily functioning, work, and relationships, impacting both patients and their families.

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years.

In clinical trials, the drug Cobenfy helped manage symptoms such as hallucinations, delusions, and disorganized thinking, which are common in schizophrenia.

Experts hope that the drug’s unique mechanism and reduced side effects will help set a new standard of care for schizophrenia patients.

Source: ABC News

https://abcnews.go.com/Health/fda-approves-1st-new-drug-schizophrenia-30-years/story?id=114070951